Home⇛The PCMC Journal⇛vol. 20 no. 2 (2024)

Factors associated with central line-associated bloodstream infection (CLABSI) among children in a tertiary government hospital: a case-control study

Joeraine Kristine L. Labapis | Mary Antonette Cuady-Madrid

Discipline: medicine by specialism

 

Abstract:

OBJECTIVE: The study aims to determine the factors associated with central line-associated bloodstream infection (CLABSI) among children admitted in a tertiary government hospital. MATERIALS AND METHODS: This was a retrospective case-control study which utilized records review of pediatric patients admitted from January 2018 to December 2022. Random sampling was employed to include confirmed cases of patients with CLABSI and controls who did not develop CLABSI. Patients were matched in terms of unit of admission. Data were collected through chart review and odds ratio was used to determine the factors associated with CLABSI using univariate and multivariate regression analysis. RESULTS: A total of 92 cases and 184 controls were included in the study. Results of multivariate regression analysis revealed that the age group of 6 to 12 years old (OR=18.91, 95% CI 2.32 to 153.9) had the highest odds of acquiring CLABSI. Blood transfusion as indication for central line insertion increased the risk of CLABSI (OR=5.24, 95% CI 1.67 to 16.48). Those more likely to acquire CLABSI were patients with duration of CVC use of more than 14 days (OR=25.68, 95% CI 2.77 to 238.4), those who received total parenteral nutrition (OR=13.44, 95% CI 2.67 to 67.56) and chemotherapeutic or immunosuppressive drugs (OR=3.07, 95% CI 1.2 to 7.85). CONCLUSION: This study revealed that age, blood transfusion as indication for central line use, receipt of total parenteral nutrition, receipt of chemotherapeutic and immunosuppressive drugs, and duration of CVC utilization of more than 14 days were found to increase the risk of CLABSI. Care-ful consideration of these factors in patients with CVCs should be observed to prevent the occurrence of CLABSI.



References:

  1. Schindler E. Vascular access in children: Technique and complications of central venous catheters. Galenika Med J [Internet]. 2023;2(6):76–82. Available from: https://scindeks.ceon.rs/Article.aspx?artid=2812-85752306068S
  2. Giacomozzi CM, Giacomozzi LM, Silva RP, Mittag BF, Nunes RC. Venous access indication algorithm for newborns in Neonatal Intensive Care Unit. Cogitare Enferm. 2023;28. doi:10.1590/ce.v28i0.89521
  3. Patel N, Bhikhoo Z, Wolmarans A, Stonestreet L, Monteith I, Phetshula Z, et al. Paediatric central venous access: Experience in the largest south African paediatric surgical centre. Wits J Clin Med [Internet]. 2020;2(3):183.
  4. Wolf J, Milstone AM. Vascular Access in Children to Prevent and Treat Infectious Diseases. Pediatrics [Internet]. 2020 Jun;145(Suppl 3):S290–1.
  5. Khieosanuk K, Fupinwong S, Tosilakul A, Sricharoen N, Sudjaritruk T. Incidence rate and risk factors of central line-associated bloodstream infections among neonates and children admitted to a tertiary care university hospital. Am J Infect Control. 2022 Jan;50(1):105–7.
  6. Park M, Seo YM, Shin YJ, Han JW, Cho E, Jang H. Factors Affecting the Timing of a Central Line Associated Bloodstream Infection Onset in Children with Cancer. J Pediatr Oncol Nurs [Internet]. 2021 Jan/Feb;38(1):26–35.
  7. Venturini E, Montagnani C, Benni A, Becciani S, Biermann KP, De Masi S, et al. Central-line associated bloodstream infections in a tertiary care children’s University hospital: a prospective study. BMC Infect Dis [Internet]. 2016 Dec 1;16(1):725.
  8. Dalia A. Abdel Rahman, Rania M. Amer, Amany M. Abd Allah. Central line associated blood stream infection : A prospective study in intensive care of Tertiary Care Children’s University Hospital. Egypt J Pediatr. 2019;36(3–4):565–79. doi:10.12816/0054725
  9. Alshahrani KM, Alhuwaishel AZ, Alangari NM, Asiri MA, Al-Shahrani NA, Alasmari AA, et al. Clinical Impacts and Risk Factors for Central Line-Associated Bloodstream Infection: A Systematic Review. Cureus [Internet]. 2023 Jun;15(6):e40954.
  10. Sellamuthu R, Nair S, Chandrasekar J, Kesavan S, Shivam V. Risk Factors of Central Line-Associated Bloodstream Infection (CLABSI): A Prospective Study From a Paediatric Intensive Care Unit in South India. Cureus [Internet]. 2023 Aug;15(8):e43349.
  11. Niedner MF, Huskins WC, Colantuoni E, Muschelli J, Harris JM 2nd, Rice TB, et al. Epidemiology of central line-associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol [Internet]. 2011 Dec;32(12):1200–8.
  12. Geldenhuys C, Dramowski A, Jenkins A, Bekker A. Central-line-associated bloodstream infections in a resource-limited South African neonatal intensive care unit. S Afr Med J [Internet]. 2017 Aug 25;107(9):758–62.
  13. See Tsai K. Risk factors for central line associated bloodstream infections among neonates with percutaneously inserted central venous catheters in Philippine Children’s Medical Center in 2015. Unpublished manuscript. Philippine Children’s Medical Center. 2016.
  14. Dubbink-Verheij GH, Bekker V, Pelsma ICM, van Zwet EW, Smits-Wintjens VEHJ, Steggerda SJ, et al. Bloodstream Infection Incidence of Different Central Venous Catheters in Neonates: A Descriptive Cohort Study. Front Pediatr [Internet]. 2017 Jun 20;5:142.
  15. Advani S, Reich NG, Sengupta A, Gosey L, Milstone AM. Central Line–Associated Bloodstream Infection in Hospitalized Children with Peripherally Inserted Central Venous Catheters: Extending Risk Analyses Outside the Intensive Care Unit. Clin Infect Dis [Internet]. 2011 May 1 [cited 2023 Sep 29];52(9):1108–15.
  16. Hsu HE, Mathew R, Wang R, Broadwell C, Horan K, Jin R, et al. Health care–associated infections among critically ill children in the US, 2013-2018. JAMA Pediatr. 2020;174(12): 1176. doi:10.1001/jamapediatrics.2020.3223
  17. Wylie MC, Graham DA, Potter-Bynoe G, Kleinman ME, Randolph AG, Costello JM, et al. Risk factors for central line–associated bloodstream infection in pediatric intensive care units. Infection Control Amp Hosp Epidemiology. 2010;31(10):1049–56. doi:10.1086/656246
  18. Broudic M, Bodet L-M, Dumont R, Joram N, Jacqmarcq O, Caillon J, et al. A 1-year survey of catheter-related infections in a Pediatric University Hospital: A prospective study. Archives de Pédiatrie. 2020;27(2):79–86. doi:10.1016/j.arcped.2019.11.004
  19. Karagiannidou S, Zaoutis T, Maniadakis N, Papaevangelou V, Kourlaba G. Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece. J Infect Public Health [Internet]. 2019 Jan 4;12(3):372–9. Available from: http://dx.doi.org/10.1016/j.jiph.2018.12.004
  20. Elward AM, Fraser VJ. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: A 2-year prospective Cohort Study. Infect Control Amp Hosp Epidemiology. 2006;27(6):553–60. doi:10.1086/505096
  21. Costello JM, Graham DA, Morrow DF, Potter-Bynoe G, Sandora TJ, Laussen PC. Risk factors for central line-associated bloodstream infection in a pediatric cardiac intensive care unit. Pediatr Crit Care Med. 2009;10(4):453–9. doi:10.1097/pcc.0b013e318198b19a
  22. Christensen ML, Hancock ML, Gattuso J, Hurwitz CA, Smith C, McCormick J, et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer. 1993;72(9):2732–8. doi:10.1002/1097-0142(19931101)72:9<2732::aid-cncr2820720934 >3.0.co;2-e
  23. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, et al. Guidelines for the provision and assessment of Nutrition Support Therapy in the adult critically ill patient: J Parenter Enter Nutr. 2009;33(3):277–316. doi:10.1177/0148607109335234
  24. Guidelines for the Prevention of Intravascular Catheter-Related Infections, Centers for     Disease Control and Prevention, 2011. Available from: https://www.cdc.gov/infectioncontrol/guidelines/bsi/index.html
  25. Page J, Tremblay M, Nicholas C, James TA. Reducing Oncology Unit Central Line-Associated Bloodstream Infections: Initial Results of a Simulation-Based Educational Intervention. J Oncol Pract. 2016 Jan;12(1):e83-7. doi: 10.1200/JOP.2015.005751.
  26. Kasi PM, Grothey A. Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients. Drugs. 2018 May;78(7):737-745. doi: 10.1007/s40265-018-0909-3.
  27. Lafuente Cabrero E, Terradas Robledo R, Civit Cuñado A, García Sardelli D, Hidalgo López C, Giro Formatger D, et al. Risk factors of catheter- associated bloodstream infection: Systematic review and meta-analysis. PLOS ONE. 2023;18(3). doi:10.1371/journal.pone.0282290
  28. Özalp Gerçeker G, Yardımcı F, Aydınok Y. Central line–associated bloodstream infections in children with hematologic and oncologic diseases: First prevalence results from a University Hospital. J Pediatr Oncol Nurs. 2019;36(5):327–36. doi:10.1177/10434 54219844226
  29. Paioni P, Kuhn S, Strässle Y, Seifert B, Berger C. Risk factors for central line–associated bloodstream infections in children with tunneled central venous catheters. Am J Infect Control. 2020;48(1):33–9. doi:10.1016/j.ajic.2019.06.027
  30. Aydın Teke T, Tanır G, Bayhan Gİ, Öz FN, Metin Ö, Özkan Ş. Clinical and microbiological features of resistant gram-negative bloodstream infections in children. J Infect Public Health. 2017;10(2):211–8. doi:10.1016/j.jiph.2016.04.011
  31. Tsai H-C, Huang L-M, Chang L-Y, Lee P-I, Chen J-M, Shao P-L, et al. Central venous catheter-associated bloodstream infections in pediatric hematology–oncology patients and effectiveness of antimicrobial lock therapy. J Microbiol Immunol Infect. 2015;48(6):639–4 doi:10.1016/j.jmii.2014.07.008
 

Tools


Copyright © 2025  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic